Patients who have recovered from Covid-19 can again get infected by the virus once the antibodies of the viral disease starts depleting, the Indian Council of Medical Research (ICMR) said on Tuesday.
India crossed 75 lakhs mark with 55,722 new COVID-19 cases and 579 deaths in last 24 hours on October 19.
The Indian Council of Medical Research (ICMR) in collaboration with a Hyderabad-based biopharmaceutical company has developed a "highly purified antisera" prepared by injecting inactivated SARS-CoV2 in horses, which can be a potential treatment for the coronavirus.
With a spike of 86,821 new cases, India's COVID-19 tally crossed 63-lakh mark on October 01.
According to the seven researchers at the Indian Council of Medical Research's National Institute of Virology in Pune, the presence of Cat Que Virus in Culex mosquitoes and pigs has been reported in China and Vietnam. They added that due to the spread of similar species of the Culex mosquitoes in India, there is a need to understand the replication kinetics of this virus.
Union Health Minister Dr. Harsh Vardhan on September 28 released 100-year timeline of history of Indian Council of Medical Research within its premises. Dr. Vardhan called it a historic day for ICMR. Health Minister said.
India's COVID tally crossed 55-lakh mark on September 22 after the country reported a spike of 75,083 new COVID-19 cases. Total COVID case tally stands at 55, 62,664, including 9,75,861 active cases, 44,97,868 discharged.
The Indian Council of Medical Research (ICMR) had placed purchase orders for COVID-19 antibody test kits to Indian firms which were cancelled subsequently with no payment made to any Chinese company.
Union Health Ministry Secretary, Rajesh Bhushan on September 15 denied the shortage of oxygen in the country and said there is sufficient oxygen for the patients.
Applauding the nation-wide lockdown to curb the spread of coronavirus, ICMR Director General Balram Bhargava on Tuesday said that the country distributed the Covid-19 curve in such a way that it did not have many deaths and did not witness a huge peak.
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.
The Indian Council of Medical Research (ICMR) has issued an advisory on the strategy for Covid-19 testing in which it has recommended "testing on demand".
Indian Council of Medical Research, Director General Balram Bhargava when asked on who is diving the pandemic, said, "Irresponsible, less cautious people who are not wearing masks are driving the pandemic in India."
Coronavirus vaccine emergency authorisation could be considered if government decides, says ICMR top official on how long people will have to wait for the vaccine as they are in the trial period.
A top ICMR official told a parliamentary panel on Wednesday that phase-two clinical trial of two indigenously developed Covid-19 vaccine candidates have almost been completed and emergency authorisation of a vaccine could be considered if the Centre decides so.
Director General of Indian Council of Medical Research, Dr Balram Bhargava on August 04 stated that Oxford vaccine, being manufactured by Serum Institute of India, got approval for phase 2 and 3 clinical trials.
The assumption that everybody is susceptible to coronavirus may not be true as 80 to 90 per cent people living in the same household where a member is diagnosed with COVID-19 do not get the disease, as per a study by the Indian Institute of Public Health Gandhinagar.
The ICMR in collaboration with the Health Ministry and the AIIMS is planning to set up the National Clinical Registry which will help researchers and policy makers understand effectiveness of investigational therapies, adverse effects taking place and generate evidence for improving the treatment of COVID-19 patients.
India's COVID-19 tally reached 15.31 lakh on July 29.
ICMR-National Institute of Cancer Prevention and Research (Noida), ICMR-National Institute for Research in Reproductive Health (Mumbai) and ICMR-National Institute of Cholera and Enteric Diseases (Kolkata) are the three facilities launched by the prime minister today.
Top News
Latest News
